EUVIMEDEUVIMED entdecken
Crossref

Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis

Yaping Xing, Fanhui Zhang, Mengdan Zhao, Hanbo Zhang, Hong Yuan iD, Tingting Meng iD

ACS Applied Bio Materials · 2026

DOI: 10.1021/acsabm.6c00680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Yaping Xing und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang310053, People's Republic of China. Hauptthemen laut MEDLINE: Endometriosis, Macrophages, Indoles, Nanoparticles. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis (EMs) is a common gynecological disorder in women of reproductive age, often presenting with pelvic pain and infertility. Its progression is closely linked to estrogen levels. While hormonal therapies are effective, long-term use can disrupt systemic hormone balance. To address this, we developed M1 macrophage membrane-derived nanovesicles (M1NVs) that leverage the natural CCL2-CCR2 targeting axis to selectively deliver drugs to ectopic endometrial lesions. The estrogen receptor antagonist bazedoxifene (BAZ) was encapsulated into M1NVs, enabling targeted delivery to ectopic tissue following systemic administration. This approach locally antagonizes estrogen signaling, resulting in effective attenuation of inflammatory infiltration, suppression of angiogenesis, and reduction of fibrosis, thereby inhibiting the growth of ectopic endometrial tissue. Importantly, it did not adversely affect ovarian or uterine structure and function. This strategy offers a targeted and efficient alternative for the treatment of endometriosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisMacrophagesIndolesNanoparticlesEndometriumBiocompatible MaterialsFemaleAnimalsHumansParticle SizeMice

Stichwörter der Autor:innen

M1 macrophagebazedoxifeneendometriosislipid nanoparticlesnanovesicles

Substanzen

IndolesbazedoxifeneBiocompatible Materials

Autor:innen und Institutionen

  • School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang310053, People's Republic of China.
  • Children's Hospital, Zhejiang University School of Medicine , Hangzhou, Zhejiang310052, People's Republic of China.
  • Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang310006, People's Republic of China.
  • College of Pharmaceutical Science, Zhejiang University, Hangzhou, Zhejiang310058, People's Republic of China.

ORCID-Profile: Hong Yuan, Tingting Meng

Zitieren

APA

Xing, Y., Zhang, F., Zhao, M., Zhang, H., Yuan, H., & Meng, T. (2026). Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00680

Vancouver

Xing Y, Zhang F, Zhao M, Zhang H, Yuan H, Meng T. Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00680

BibTeX
@article{Xing2026,
  author = {Xing, Yaping and Zhang, Fanhui and Zhao, Mengdan and Zhang, Hanbo and Yuan, Hong and Meng, Tingting},
  title = {Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c00680}
}
Kostenlos starten →